WNT5A and Miyoshi myopathy: WNT5A produced by MSCs in MM can act as a growth factor for tumor cells and increase osteoclast activity [43], which may explain the increased amount of WNT5A in this patient (although it does not explain the low levels of the protein in the other patients and in HD).